Quantinno Capital Management LP Has $2.28 Million Stock Position in Humana Inc. (NYSE:HUM)

Quantinno Capital Management LP decreased its position in Humana Inc. (NYSE:HUM - Free Report) by 64.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,204 shares of the insurance provider's stock after selling 13,126 shares during the period. Quantinno Capital Management LP's holdings in Humana were worth $2,282,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. PDT Partners LLC lifted its stake in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after buying an additional 2,660 shares during the period. Ontario Teachers Pension Plan Board lifted its stake in Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after buying an additional 71,910 shares during the period. Swedbank AB lifted its stake in Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider's stock valued at $33,567,000 after buying an additional 3,085 shares during the period. Heritage Oak Wealth Advisors LLC acquired a new position in Humana in the second quarter valued at about $3,456,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in Humana by 3.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider's stock valued at $284,810,000 after buying an additional 26,056 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on HUM shares. JPMorgan Chase & Co. raised their price target on Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 21st. Oppenheimer dropped their price target on Humana from $400.00 to $280.00 and set an "outperform" rating on the stock in a research report on Thursday, October 3rd. Leerink Partnrs lowered Humana from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 2nd. Truist Financial dropped their price target on Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a research report on Friday, October 11th. Finally, Jefferies Financial Group lowered Humana from a "buy" rating to a "hold" rating and dropped their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $315.86.

Humana Stock Performance

NYSE:HUM traded down $7.19 during mid-day trading on Wednesday, hitting $278.63. 874,668 shares of the stock were exchanged, compared to its average volume of 1,840,170. The stock has a market capitalization of $33.55 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 2.18 and a beta of 0.53. The firm's 50-day simple moving average is $272.20 and its 200 day simple moving average is $325.92. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $488.89.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts anticipate that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.27%. Humana's dividend payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.